INDRAPRASTHA MEDICAL CORPORATION
|
INDRAPRASTHA MEDICAL CORPORATION Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 20.03 | 17.56 | 13.52 | 9.40 | 6.39 |
| CEPS(Rs) | 24.79 | 22.40 | 17.89 | 13.68 | 10.21 |
| DPS(Rs) | 4.00 | 4.50 | 4.50 | 3.00 | 2.50 |
| Book NAV/Share(Rs) | 80.76 | 65.09 | 52.12 | 41.39 | 35.50 |
| Tax Rate(%) | 25.36 | 25.58 | 25.37 | 26.48 | 25.86 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.00 | 18.01 | 15.53 | 13.72 | 12.87 |
| EBIT Margin(%) | 17.00 | 16.41 | 13.67 | 11.06 | 9.29 |
| Pre Tax Margin(%) | 16.59 | 15.95 | 13.35 | 10.67 | 8.90 |
| PAT Margin (%) | 12.39 | 11.87 | 9.96 | 7.84 | 6.60 |
| Cash Profit Margin (%) | 15.33 | 15.14 | 13.18 | 11.42 | 10.53 |
| Performance Ratios | |||||
| ROA(%) | 19.93 | 20.44 | 19.39 | 16.94 | 13.12 |
| ROE(%) | 27.47 | 29.97 | 28.92 | 24.44 | 19.60 |
| ROCE(%) | 37.70 | 41.43 | 39.70 | 34.46 | 27.58 |
| Asset Turnover(x) | 1.61 | 1.72 | 1.95 | 2.16 | 1.99 |
| Sales/Fixed Asset(x) | 2.50 | 2.40 | 2.34 | 2.27 | 1.92 |
| Working Capital/Sales(x) | 6.00 | 5.37 | 8.73 | 11.76 | 13.55 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.40 | 0.42 | 0.43 | 0.44 | 0.52 |
| Receivable days | 23.10 | 18.01 | 18.57 | 18.54 | 22.75 |
| Inventory Days | 1.83 | 1.95 | 2.34 | 3.06 | 3.85 |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 18.55 | 21.98 | 12.70 | 8.27 | 9.14 |
| PCE(x) | 14.99 | 17.24 | 9.60 | 5.68 | 5.73 |
| Price/Book(x) | 4.60 | 5.93 | 3.30 | 1.88 | 1.65 |
| Yield(%) | 1.08 | 1.17 | 2.62 | 3.86 | 4.28 |
| EV/Net Sales(x) | 2.12 | 2.37 | 1.08 | 0.53 | 0.53 |
| EV/Core EBITDA(x) | 10.63 | 12.05 | 6.42 | 3.63 | 3.98 |
| EV/EBIT(x) | 12.47 | 14.45 | 7.93 | 4.81 | 5.67 |
| EV/CE(x) | 4.25 | 5.39 | 2.83 | 1.54 | 1.44 |
| M Cap / Sales | 2.30 | 2.61 | 1.26 | 0.65 | 0.60 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 9.30 | 8.97 | 13.29 | 23.70 | 44.80 |
| Core EBITDA Growth(%) | 10.77 | 26.95 | 30.81 | 36.88 | 186.74 |
| EBIT Growth(%) | 13.23 | 30.80 | 40.10 | 47.26 | 981.00 |
| PAT Growth(%) | 14.06 | 29.87 | 43.89 | 46.96 | 2,415.88 |
| EPS Growth(%) | 14.06 | 29.87 | 43.89 | 46.96 | 2,415.62 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.46 | 2.41 | 1.86 | 1.72 | 1.70 |
| Quick Ratio(x) | 2.41 | 2.37 | 1.82 | 1.66 | 1.59 |
| Interest Cover(x) | 41.87 | 35.50 | 41.91 | 28.38 | 24.19 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of INDRAPRASTHA MEDICAL CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAPRASTHA MEDICAL CORPORATION | ₹3,028.9 Cr | -2.1% | 0.7% | -39.4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹122,440.0 Cr | 1.3% | 9% | 13% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹91,979.4 Cr | 2.2% | 10.8% | -14% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹62,952.2 Cr | -3.8% | 6.9% | 8.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,754.3 Cr | -1.1% | 2.1% | -23.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,062.2 Cr | -3.1% | 10.2% | 1.4% | Stock Analytics | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | -2.1% |
0.7% |
-39.4% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses
